Ocular Therapeutix
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ocular Therapeutix's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13% to $58,443,000. Profit margin reached -138%. Total operating expenses were $135,544,000.

Profit Margin

Ocular Therapeutix, Inc. (NASDAQ:OCUL): Profit margin
2014 772K -28.64M -3710.88%
2015 1.75M -39.74M -2271.31%
2016 1.88M -44.70M -2369%
2017 1.92M -63.38M -3296.2%
2018 1.99M -57.69M -2899.1%
2019 4.22M -89.93M -2127.63%
2020 17.40M -159.63M -917.26%
2021 43.52M -10.80M -24.82%
2022 51.49M -63.42M -123.16%
2023 58.44M -80.73M -138.14%

OCUL Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
58.44M51.49M43.52M17.40M4.22M1.99M1.92M1.88M1.75M772K
Cost of revenue
5.28M4.54M4.40M2.08M2.32M465K457K443K319K91K
Gross profit
53.16M46.95M39.11M15.32M1.90M1.52M1.46M1.44M1.43M681K
Operating exp.
Research and development
61.05M53.46M50.08M28.69M41.09M36.91M30.88M27.06M26.61M18.88M
Selling and marketing
40.54M39.92M35.19M26.61M24.49M4.94M17M6.70M3.85M1.98M
Total operating expenses
135.54M125.60M117.15M78.16M87.70M60.64M63.38M44.77M39.62M27.77M
Operating income
-82.38M-78.65M-78.03M-62.84M-85.80M-59.11M-61.92M-43.32M-38.19M-27.09M
Other income (expenses), net
1.64M7.61M71.48M-92.78M-570K-860K-1.46M-1K-1.55M-1.55M
Income before tax
-80.73M-71.03M-6.55M-155.63M-86.37M-59.97M-63.38M-44.70M-39.74M-28.64M
Income tax expense
0-7.61M4.25M3.99M3.56M-2.28M272K798K977K130K
Net income
-80.73M-63.42M-10.80M-159.63M-89.93M-57.69M-63.38M-44.70M-39.74M-28.64M
Earnings per share
Basic EPS
-1.09-0.83-0.14-2.63-1.99-1.51-2.2-1.8-1.71-2.69
Diluted EPS
-1.02-0.83-0.13-2.63-1.99-1.51-2.2-1.8-1.71-2.69
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source